Allogene Therapeutics, Inc. Annual Operating Lease, Payments in USD from 2020 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Allogene Therapeutics, Inc. annual/quarterly Operating Lease, Payments history and growth rate from 2020 to 2024.
  • Allogene Therapeutics, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $3.1M, a 3.33% increase year-over-year.
  • Allogene Therapeutics, Inc. annual Operating Lease, Payments for 2024 was $12.5M, a 4.17% increase from 2023.
  • Allogene Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $12M, a 26.3% increase from 2022.
  • Allogene Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $9.5M, a 58.3% increase from 2021.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $12.5M +$500K +4.17% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-13
2023 $12M +$2.5M +26.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-14
2022 $9.5M +$3.5M +58.3% Jan 1, 2022 Dec 31, 2022 10-K/A 2024-03-14
2021 $6M -$200K -3.23% Jan 1, 2021 Dec 31, 2021 10-K 2022-02-23
2020 $6.2M Jan 1, 2020 Dec 31, 2020 10-K 2021-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.